NCT06653010View on ClinicalTrials.gov

Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

October 20, 2027

Study Completion Date

December 30, 2027

Conditions
CRC (Colorectal Cancer)Metastatic Colorectal Cancer
Interventions
BIOLOGICAL

Universal CAR-T cells injection for treating mCRC

A novel universal CAR-T platform to treat cancer patients

Trial Locations (1)

710061

RECRUITING

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Wondercel Biotech (ShenZhen)

INDUSTRY